The risk of paracetamol overdose to the liver is further prevented. The National Agency for the Safety of Medicines and Health Products (ANSM) is therefore asking laboratories to include warning messages on paracetamol-containing medicine boxes. This measure affects more than 200 medicines marketed in France.
For medicinal products based solely on paracetamol, the ANSM requests that the following statement be included on the front of the pack:
Please note
This will be supplemented by information on the back of the pack (maximum dose per dose per day, timing between doses, not taking another medicine containing paracetamol).
Do not take another medicine containing paracetamol
Furthermore, for medicinal products based on paracetamol in combination with another active substance, the ANSM requests the following elements to be inserted on the front of the pack:
